144 related articles for article (PubMed ID: 22138011)
21. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
[TBL] [Abstract][Full Text] [Related]
22. Molecular assays to profile 10 estrogen receptor beta isoform mRNA copy numbers in ovary, breast, uterus, and bone tissues.
Poola I
Endocrine; 2003 Nov; 22(2):101-12. PubMed ID: 14665713
[TBL] [Abstract][Full Text] [Related]
23. Estrogen receptors in the uterus and ovarian follicles of gilts treated with dihydrotestosterone.
Cárdenas H; Pope WF
Domest Anim Endocrinol; 2005 Oct; 29(3):523-33. PubMed ID: 16153501
[TBL] [Abstract][Full Text] [Related]
24. Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma.
Niikawa H; Suzuki T; Miki Y; Suzuki S; Nagasaki S; Akahira J; Honma S; Evans DB; Hayashi S; Kondo T; Sasano H
Clin Cancer Res; 2008 Jul; 14(14):4417-26. PubMed ID: 18579664
[TBL] [Abstract][Full Text] [Related]
25. Estrogenic Effects of the Extracts from the Chinese Yam (Dioscorea opposite Thunb.) and Its Effective Compounds in Vitro and in Vivo.
Zeng M; Zhang L; Li M; Zhang B; Zhou N; Ke Y; Feng W; Zheng X
Molecules; 2018 Jan; 23(2):. PubMed ID: 29360751
[TBL] [Abstract][Full Text] [Related]
26. Assessing estrogenic activity of pyrethroid insecticides using in vitro combination assays.
Kim IY; Shin JH; Kim HS; Lee SJ; Kang IH; Kim TS; Moon HJ; Choi KS; Moon A; Han SY
J Reprod Dev; 2004 Apr; 50(2):245-55. PubMed ID: 15118252
[TBL] [Abstract][Full Text] [Related]
27. Aromatase overexpression induces malignant changes in estrogen receptor α negative MCF-10A cells.
Wang J; Gildea JJ; Yue W
Oncogene; 2013 Oct; 32(44):5233-40. PubMed ID: 23178495
[TBL] [Abstract][Full Text] [Related]
28. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
Treeck O; Lattrich C; Springwald A; Ortmann O
Breast Cancer Res Treat; 2010 Apr; 120(3):557-65. PubMed ID: 19434490
[TBL] [Abstract][Full Text] [Related]
29. Genistein modulates oxidative stress in breast cancer cell lines according to ERα/ERβ ratio: effects on mitochondrial functionality, sirtuins, uncoupling protein 2 and antioxidant enzymes.
Nadal-Serrano M; Pons DG; Sastre-Serra J; Blanquer-Rosselló Mdel M; Roca P; Oliver J
Int J Biochem Cell Biol; 2013 Sep; 45(9):2045-51. PubMed ID: 23871935
[TBL] [Abstract][Full Text] [Related]
30. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
Dardes RC; Schafer JM; Pearce ST; Osipo C; Chen B; Jordan VC
Gynecol Oncol; 2002 Jun; 85(3):498-506. PubMed ID: 12051881
[TBL] [Abstract][Full Text] [Related]
31. The androgen metabolite 5alpha-androstane-3beta,17beta-diol (3betaAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance.
Sikora MJ; Cordero KE; Larios JM; Johnson MD; Lippman ME; Rae JM
Breast Cancer Res Treat; 2009 May; 115(2):289-96. PubMed ID: 18521740
[TBL] [Abstract][Full Text] [Related]
32. Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells.
Secreto FJ; Monroe DG; Dutta S; Ingle JN; Spelsberg TC
J Cell Biochem; 2007 Aug; 101(5):1125-47. PubMed ID: 17520659
[TBL] [Abstract][Full Text] [Related]
33. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
[TBL] [Abstract][Full Text] [Related]
34. Estrogen-induced growth inhibition of human seminoma cells expressing estrogen receptor beta and aromatase.
Roger C; Lambard S; Bouskine A; Mograbi B; Chevallier D; Nebout M; Pointis G; Carreau S; Fenichel P
J Mol Endocrinol; 2005 Aug; 35(1):191-9. PubMed ID: 16087732
[TBL] [Abstract][Full Text] [Related]
35. Identification of coregulators influenced by estrogen receptor subtype specific binding of the ER antagonists 4-hydroxytamoxifen and fulvestrant.
Evers NM; Wang S; van den Berg JH; Houtman R; Melchers D; de Haan LH; Ederveen AG; Groten JP; Rietjens IM
Chem Biol Interact; 2014 Sep; 220():222-30. PubMed ID: 25014417
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of histone proteins during estrogen-mediated cell proliferation.
Zhu Z; Edwards RJ; Boobis AR
Environ Health Perspect; 2009 Jun; 117(6):928-34. PubMed ID: 19590685
[TBL] [Abstract][Full Text] [Related]
37. Validation of real-time RT-PCR for analysis of human breast cancer cell lines resistant or sensitive to treatment with antiestrogens.
de Cremoux P; Tran-Perennou C; Brockdorff BL; Boudou E; Brünner N; Magdelénat H; Lykkesfeldt AE
Endocr Relat Cancer; 2003 Sep; 10(3):409-18. PubMed ID: 14503918
[TBL] [Abstract][Full Text] [Related]
38. ERβ-dependent effects on uterine endothelial cells are cell specific and mediated via Sp1.
Greaves E; Collins F; Critchley HO; Saunders PT
Hum Reprod; 2013 Sep; 28(9):2490-501. PubMed ID: 23756706
[TBL] [Abstract][Full Text] [Related]
39. Repeated Exposure to 4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP), an Active Metabolite of Bisphenol A, Aggressively Stimulates Breast Cancer Cell Growth in an Estrogen Receptor
Hirao-Suzuki M; Takeda S; Okuda K; Takiguchi M; Yoshihara S
Mol Pharmacol; 2019 Mar; 95(3):260-268. PubMed ID: 30552153
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of aromatase inhibitors and antiestrogens on estrogen receptor expression in breast cancer cells.
Smollich M; Götte M; Fischgräbe J; Radke I; Kiesel L; Wülfing P
Anticancer Res; 2009 Jun; 29(6):2167-71. PubMed ID: 19528477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
